Monk, B. J., Corr, B., Mei, L., Opneja, A., Patel, V., Altomare, I., Ferhat, A., Puvvada, S. D., Stirnadel-Farrant, H. A., Schmidt, J., Sarlo, K., Zhang, T., Beckermann, K. E. (2026). A pragmatic, hybrid observational study evaluating the effectiveness of trastuzumab deruxtecan (T-DXd) in patients with human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) 3+ solid tumors: DESTINY-PanTumor04.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps11202